-
Posted by
Two Blokes Jun 15 -
Filed in
Stock
-
8 views
Eli Lilly (LLY 0.90%) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical wins, the company may even be taking the lead ahead of its only real competitor in the field, Novo Nordisk.